Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
36.87
+0.18 (0.49%)
Apr 24, 2026, 1:14 PM EDT - Market open
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $2.19 billion as of April 24, 2026. Its market cap has increased by 485.15% in one year.
Market Cap
2.19B
Enterprise Value
1.98B
1-Year Change
485.15%
Ranking
Category
Stock Price
$36.87
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $2.19B, an increase of 235.03%. That is a compound annual growth rate of 30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 2.18B | 55.54% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 2.04B |
| Capricor Therapeutics | 2.01B |
| Ocular Therapeutix | 1.98B |
| Galapagos NV | 1.93B |
| Sionna Therapeutics | 1.93B |
| Recursion Pharmaceuticals | 1.92B |
| Pharvaris | 1.91B |
| Palvella Therapeutics | 1.90B |